As of 2024, nervous system medicine sales in the UK, expressed in US Dollars per capita, are forecasted to show a declining trend. Beginning at 62.2 in 2024, the values progressively decrease each year to reach 61.1 by 2028. This indicates a subtle, yet steady decrease over the five-year period. From actual data up to 2023, the market's sales showed some fluctuations, and this forecast continues the gradual downward trend. The year-on-year variation percentages present a consistent, albeit slight, decline.
Future trends to watch for include innovations in neurology treatments, potential shifts in health care policies impacting drug pricing, and demographic changes particularly an aging population which may influence demand for nervous system medicines.
